The Effect of Exercise Intervention on the Community's Older Adults
The Effect of Exercise Intervention on the Physical Fitness, Bone Mineral Density and Health-related Quality of Life in the Community's Older Adults
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Pizi, Taiwan, 613
- Sports Medicine Center, Chang Gung Memorial Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Being >45 years-of-age,
- Healthy and physically independent.
Exclusion Criteria:
- The exclusion criteria were individuals on hormone replacement therapy and those with cognitive impairment, progressive debilitating conditions, bone fractures, or any medical contraindications to administering the fitness assessment.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Kein Eingriff: Control
without exercise intervention
|
|
|
Experimental: Exercise
Subjects with circuit exercise, aerobic dance, or Tai Chi exercise intervention.
|
circuit exercise, aerobic dance and Tai Chi exercise
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from baseline bone mineral density
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Bone mineral density measurement is measured by dual-energy x-ray absorptiometry (DXA).
Measurements are made over the lumbar spine and over the upper part of the hip and the measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from baseline elbow muscle strength
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of elbow were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline shoulder muscle strength
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of shoulder were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline hip muscle strength
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of hip were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline knee muscle strength
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of knee were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline SF-36 questionnaire assessment
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower score the more disability.
The higher the score the less disability.
Eight sections including physical function, role limitation due to physical problems, bodily pain, general health, vitality, social functioning, role limitation due to emotional problems, and mental health.
Additionally, the eight health domains can be used to provide a physical component summary and mental component summary score.
The outcome measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
High-density lipoprotein from blood sample
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
High-density lipoprotein are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Triglyceride from blood sample
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Triglyceride are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Fasting blood glucose from blood sample
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Fasting blood glucose are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Blood pressure
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Diastolic and systolic blood pressure are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Weight parameters of the subjects
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Weight (kg) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Height parameters of the subjects
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Height (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Waistline parameters of the subjects
Zeitfenster: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Waistline (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Hauptermittler: Robert Wen-Wei HSU, MD, Sports Medicine Center, Chang Gung Memorial Hospital, Chiayi
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- CMRPG690111-3;CMRPG6A0421-22
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .